Sentences with phrase «cancer research center investigators»

Research is critical to understanding the unique health challenges these survivors face, and Fred Hutchinson Cancer Research Center investigators lead the way in examining long - term outcomes as well as interventions that help these patients take control of their health and happiness.

Not exact matches

Dr. Larry Corey, Principal Investigator, HIV Vaccine Trials Network; Past President and Director, Fred Hutchinson Cancer Research Center Dr. Diane Havlir, Professor of Medicine, University of California, San Francisco Moderator: Siobhan O'Connor, Time Magazine

For example, the pot of money allocated for investigator - initiated cancer research could grow more slowly; the fact sheet also does not mention what is envisioned for NCI's cancer centers.

What drew these scientists to Maryland's Eastern Shore was the National Cancer Institute's (NCI's) Center for Cancer Research Fellows and Young Investigators (CCR - FYI) Third Annual Retreat.

This is the main finding of new research led by investigators at NYU Langone Medical Center and its Perlmutter Cancer Center and published online May 19 in the Journal of the National Cancer Institute.

UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver DResearch, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.

It is «not large research consortia, not new technologies, not cancer centers,» Weinberg said, but the young individual investigator.

The Center for Cancer Research, the main division, is down 43 principal investigators (PIs) to 275, says CCR Director Robert Wiltrout.

Principal investigator Leena Gandhi, MD, PhD, director of the thoracic medical oncology program at Perlmutter Cancer Center at NYU Langone Health and associate professor of Medicine in the division of Medical Oncology at NYU School of Medicine, presented these findings April 16 at the American Association for Cancer Research (AACR) Annual Meeting 2018 in Chicago.

«The findings of both studies support a growing body of research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stcancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both studies.

«We can use expansion pathology to push conventional light microscopes beyond their current limits, which could have important applications in diagnostic pathology,» said the study's co-lead author, Octavian Bucur, MD, PhD, of the Department of Pathology and Cancer Research Institute at BIDMC, who is also a Ludwig Cancer Center Research Investigator.

«Given the serious threat of graft - versus - host disease, new approaches to make stem cell transplants safer for patients remain a critical unmet need,» said Dr. Leslie Kean, the trial's principal investigator and associate director of the Ben Towne Center for Childhood Cancer Research at Seattle Children's.

In a randomized, phase 2 multi-center clinical study, led by Manisha Shah, MD of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutaCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), investigators tested the effectiveness of the targeted therapy drug, dabrafenib (pronounced «da bRAF e nib» and marketed as Tafinlar), given alone compared with the same drug given in combination with trametinib (pronounced «tra ME ti nib,» marketed at MeKinist) to treat a subset of advanced papillary thyroid cancer patients with B - raf mutacancer patients with B - raf mutations.

Screening for colorectal cancer based on age alone may contribute to both underuse and overuse of the tests among older patients, according to a study by investigators at the University of Michigan and the Veterans Affairs Center for Clinical Management Research.

The MD / PhD program at UT Houston and the Anderson Cancer Center was designed to train investigators who could better bridge the gap between basic science and clinical research, and as an alternative to the traditional MSTP program model.

«We challenged a current dogma in the field that emphasized PLK1's role in mitosis (cell division) as a primary mechanism for cancer growth,» says Zheng Fu, Ph.D., lead investigator on the study, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medcancer growth,» says Zheng Fu, Ph.D., lead investigator on the study, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of MedCancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of MedCancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medicine.

«Ultimately, the virus is suppressing the immune system for its own benefit, and promoting the formation and proliferation of cancer cells may be just a side effect of that,» says Sharon Kuss - Duerkop, PhD, research instructor working in the lab of CU Cancer Center investigator Dohun Pyeoncancer cells may be just a side effect of that,» says Sharon Kuss - Duerkop, PhD, research instructor working in the lab of CU Cancer Center investigator Dohun PyeonCancer Center investigator Dohun Pyeon, PhD.

Rather than disentangling entire cells, HHMI investigator Steven Henikoff and postdoctoral researcher Roger Deal at the Fred Hutchinson Cancer Research Center had simplified the problem by isolating only the nuclei of the cells they were interested in.

The research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inresearch team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InstCancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InResearch Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

Alizadeh and Diehn are both investigators at the Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford.

Now researchers working on canine cancer have an authenticated resource similar to what's available for human cancers,» says Daniel L. Gustafson, PhD, CU Cancer Center investigator and director for basic research at the Flint Animal Cancer Ccancer have an authenticated resource similar to what's available for human cancers,» says Daniel L. Gustafson, PhD, CU Cancer Center investigator and director for basic research at the Flint Animal Cancer CCancer Center investigator and director for basic research at the Flint Animal Cancer CCancer Center.

While dietary supplements may be advertised to promote health, a forum at the American Association for Cancer Research (AACR) Annual Meeting 2015 by University of Colorado Cancer Center investigator Tim Byers, MD, MPH, describes research showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietary aCancer Research (AACR) Annual Meeting 2015 by University of Colorado Cancer Center investigator Tim Byers, MD, MPH, describes research showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietaryResearch (AACR) Annual Meeting 2015 by University of Colorado Cancer Center investigator Tim Byers, MD, MPH, describes research showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietary aCancer Center investigator Tim Byers, MD, MPH, describes research showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietaryresearch showing that over-the-counter supplements may actually increase cancer risk if taken in excess of the recommended dietary acancer risk if taken in excess of the recommended dietary amount.

Olivier Rixe, MD, PhD, Associate Center Director for Clinical Research at the UNM Comprehensive Cancer Center, serves as a National Principal Investigator for these clinical trials.

«Our research reveals a new regulatory mechanism that coordinates two distinct intracellular processes that are critical to cellular homeostasis and disease development,» said Chengyu Liang, M.D., Ph.D., a member of the USC Norris Comprehensive Cancer Center and principal investigator of the study.

Greenberg is also an associate investigator at the Abramson Family Cancer Research Institute and director of Basic Science for the Basser Center for BRCA.

«Salmonella strains have a natural preference for infiltrating and replicating within the cancer cells of a tumor, making the bacteria an ideal candidate for bacteriotherapy,» said Robert Kazmierczak, a senior investigator at the Cancer Research Center and a post-doctoral fellow in the Division of Biological Sciences in the MU College of Arts and Sccancer cells of a tumor, making the bacteria an ideal candidate for bacteriotherapy,» said Robert Kazmierczak, a senior investigator at the Cancer Research Center and a post-doctoral fellow in the Division of Biological Sciences in the MU College of Arts and ScCancer Research Center and a post-doctoral fellow in the Division of Biological Sciences in the MU College of Arts and Science.

Now a research team led by investigators in the Cancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC), has identified an inhibitor of the Pin1 enzyme that can address both of these challenges in acute promyelocytic leukemia (APL) and triple negative breastresearch team led by investigators in the Cancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC), has identified an inhibitor of the Pin1 enzyme that can address both of these challenges in acute promyelocytic leukemia (APL) and triple negative breast cCancer Research Institute at Beth Israel Deaconess Medical Center (BIDMC), has identified an inhibitor of the Pin1 enzyme that can address both of these challenges in acute promyelocytic leukemia (APL) and triple negative breastResearch Institute at Beth Israel Deaconess Medical Center (BIDMC), has identified an inhibitor of the Pin1 enzyme that can address both of these challenges in acute promyelocytic leukemia (APL) and triple negative breast cancercancer.

Abramson Cancer Center investigators pay particular attention to actively including women and minority populations in their research efforts.

Dr. Roggin collaborates with other clinicians and investigators in the University of Chicago Cancer Research Center.

In 1999, with his PhD in hand, Dr. Malik took the postdoc track to Seattle, Washington, for a position at the Fred Hutchinson Cancer Research Center, where he began work with investigator Steven Henikoff on centromeres (repetitive sequences of DNA that do not code for proteins), advancing his hypotheses on evolutionary gene conflict.

Nobel Laureate in Physiology or Medicine Full Member, Basic Sciences Division Fred Hutchinson Cancer Research Center Affiliate Professor of Physiology and Biophysics University of Washington, Seattle Investigator, Howard Hughes Medical Institute

«Our study offers the first evidence — seen in breast tissue — that high saturated fatty acids in the breast adipose tissue is associated with presence of breast cancer in postmenopausal women,» says senior author and investigator Sungheon G. Kim, PhD, associate professor in the Department of Radiology at NYU Langone and a researcher at the Center for Advanced Imaging, Innovation, and Research.

The Divisions of Cancer Prevention (DCP) and Cancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cCancer Prevention (DCP) and Cancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cCancer Biology (DCB) at the National Institutes of Health (NIH) has awarded a $ 6 million grant to investigators at the University of Michigan to continue support for a Research Center in the Barrett's Esophagus Translational Research Network (BETRNet)-- this consortium studies the connection between Barrett's esophagus and risk for developing esophageal cancercancer.

Brentnall collaborates with Center investigators Drs. Sunil Hingorani, Meg Mandelson and John Potter on other pancreatic - cancer research.

Carl June is currently the director of the Translational Research Program at the Abramson Cancer Center at the University of Pennsylvania, and is an Investigator of the Abramson Family Cancer Research Institute.

The NCI grant funding to the cancer centers supports shared research resources, provides developmental funds to advance scientific goals, and fosters cancer programs that draw investigators from different disciplines together.

He also chairs the Cancer Center Advisory Committee, serves as principal investigator of St. Jude's Cancer Center Support Grant from the National Cancer Institute (NCI), is co-principal investigator of the Collaborative Ependymoma Research Network, and holds the Lillian R. Cannon endowed chair.

The tests are based on research conducted by Columbia University Irving Medical Center (CUIMC) investigators — and could pave the way for a more precise approach to cancer therapy and help find effective drugs when conventional approaches to precision medicine have failed.

Dana - Farber Cancer Institute, Harvard Medical School, Boston MA, USA 1989 — 1991 Universitair Docent, Department of Clinical Immunology, University of Utrecht 1991 — 2002 Professor and Chairman, Dept. of Immunology, Faculty of Medicine, University of Utrecht 2002 — 2012 Director of the Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences 2002 — Professor in Molecular Genetics, University Medical Center Utrecht 2012 — 2015 President of the Royal Netherlands Academy of Sciences 2015 — Director Research of the Princess Máxima Center for pediatric oncology 2017 — Oncode Investigator

Indeed, research proposals from cancer center investigators account for about three - quarters of the successful investigator - initiated grants that are awarded by NCI.

In addition to his role at Chicago Center for Health Equity Research, Robert Winn is the primary investigator in a lab at the University of Illinois at Chicago that explores signaling pathways in lung cancer.

John and Donna Hall of Lexington, Ky., endowed the Donna S. Hall Chair in Breast Cancer at Vanderbilt - Ingram Cancer Center to support the research efforts of an exceptional cancer investigator in the breast cancer prCancer at Vanderbilt - Ingram Cancer Center to support the research efforts of an exceptional cancer investigator in the breast cancer prCancer Center to support the research efforts of an exceptional cancer investigator in the breast cancer prcancer investigator in the breast cancer prcancer program.

Margaret M. Van Bree, president of Rhode Island Hospital and Hasbro Children's Hospital, said, «At the Rhode Island Hospital Center for Cancer Research Development, we created an environment to foster career development among promising investigators by equipping them with what's needed for progressive rResearch Development, we created an environment to foster career development among promising investigators by equipping them with what's needed for progressive researchresearch.

Results of the international trial, led by principal investigator Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, deputy director of Perlmutter Cancer Center, and co-leader of its Melanoma Research Program, were published in November 2017 in The New England Journal of Medicine.

The guests deliver a research seminar for Cancer Center members and are paired with a junior or mid-level clinical investigator to promote collaboration, networking and mentorship opportunities.

Funding provided by the Cancer Center Support Grant (CCSG) supports several types of pilot projects (1) highly innovative pilot projects focusing on proof - of - concept or translational research; (2) preliminary collaborative investigations that lead to multi-investigator grant awards or clinical trial; (3) projects that closely align with the Cancer Center's strategic plan and enhance key initiatives; and (4) pilot funding for junior investigators to jump - start independent projects or for more senior investigators looking to study a novel idea derived from discovery.

Investigators at the Gene Editing Institute, which is part of the Helen F. Graham Cancer Center & Research Institute at Christiana Care, said their new «cell - free» CRISPR technology is the first CRISPR tool capable of making multiple edits to DNA samples «in vitro,» which means in a test tube or petri dish.

The ITCMS postdoctoral training program at the UNC Lineberger Comprehensive Cancer Center provides an exceptional interdisciplinary training experience, including outstanding basic and translational research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on cancer model syCancer Center provides an exceptional interdisciplinary training experience, including outstanding basic and translational research opportunities with renowned investigators, and an extensive scope of workshops and training modules with an emphasis on cancer model sycancer model systems.

When people with HIV don't take antiretrovirals, they might expect to live for about 6 months, says Larry Corey, MD, a principal investigator for the HIV Vaccine Trials Network at the Fred Hutchinson Cancer Research Center in Seattle.

Oncology investigators in the NC State Center for Comparative Medicine and Translational Research, for example, focus on understanding the pathogenesis and treatment of cancer through studies involving, in part, spontaneous models of cancer provided by Terry Center oncology patients.